Intercept Pharmaceuticals competitors

Intercept Pharmaceuticals Competitors include Regulus Therapeutics, Anthera Pharmaceuticals, PTC Therapeutics and Athersys.
Add company...
Intercept Pharmaceuticals
Intercept Pharmaceuticals
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Anthera Pharmaceuticals
Anthera Pharmaceuticals
Anthera Pharmaceuticals is focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.
PTC Therapeutics
PTC Therapeutics
PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs.
Athersys
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Founding Date
Founding Date
2002
Founding Date
2007
Founding Date
2004
Founding Date
1998
Founding Date
1995
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Wien, AT
Mississauga, CA
Kongens Lyngby, DK
Paris, FR
München, DE
Milano, IT
see more
Locations
San Diego, US HQ
Locations
Hayward, US HQ
Locations
South Plainfield, US HQ
Locations
Cleveland, US HQ
Canton, US
Employees
Employees
50711% increase
Employees
608% decrease
Employees
33
Employees
36620% increase
Employees
6610% increase
Valuation ($)
Valuation ($)
3.1 b
Valuation ($)
12 m
Valuation ($)
3.1 m
Valuation ($)
1.6 b
Valuation ($)
243.8 m
Twitter followers
Twitter followers
1.8 k
Twitter followers
671
Twitter followers
343
Twitter followers
333
Twitter followers
953

Financial

Revenue (est.)
Revenue (est.)
$131m (FY, 2017)
Revenue (est.)
$72k (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$194.4m (FY, 2017)
Revenue (est.)
$3.7m (FY, 2017)
Net income
Net income
($360.4m) (FY, 2017)
Net income
($71.9m) (FY, 2017)
Net income
($26.9m) (FY, 2017)
Net income
N/A
Net income
N/A

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
300 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
200 (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 55m
Total funding raised
$ 10m
Total funding raised
$ 31.5m
Total funding raised
N/A
Total funding raised
$ 9m
For sources of this data, please see the company profileDownload Excel

View company profiles

Regulus Therapeutics
HQ
San Diego, US
Employees
60↓ 8% decrease

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company
Anthera Pharmaceuticals
HQ
Hayward, US
Employees
33

Anthera Pharmaceuticals is focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

View company
PTC Therapeutics
HQ
South Plainfield, US
Employees
366↑ 20% increase

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs.

View company
Athersys
HQ
Cleveland, US
Employees
66↑ 10% increase

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company